A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation

Evidence suggests that the growth and therapeutic resistance of glioblastoma (GBM) may be enabled by a population of glioma stem cells (GSCs) that are regulated by typical stem cell pathways, including the WNT/β-catenin signaling pathway. We wanted to explore the effect of treating GSCs with a small...

Full description

Bibliographic Details
Main Authors: Kirsten Strømme Kierulf-Vieira, Cecilie Jonsgar Sandberg, Jo Waaler, Kaja Lund, Erlend Skaga, Birthe Mikkelsen Saberniak, Ioannis Panagopoulos, Petter Brandal, Stefan Krauss, Iver Arne Langmoen, Einar Osland Vik-Mo
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/6/1630
_version_ 1797564774442074112
author Kirsten Strømme Kierulf-Vieira
Cecilie Jonsgar Sandberg
Jo Waaler
Kaja Lund
Erlend Skaga
Birthe Mikkelsen Saberniak
Ioannis Panagopoulos
Petter Brandal
Stefan Krauss
Iver Arne Langmoen
Einar Osland Vik-Mo
author_facet Kirsten Strømme Kierulf-Vieira
Cecilie Jonsgar Sandberg
Jo Waaler
Kaja Lund
Erlend Skaga
Birthe Mikkelsen Saberniak
Ioannis Panagopoulos
Petter Brandal
Stefan Krauss
Iver Arne Langmoen
Einar Osland Vik-Mo
author_sort Kirsten Strømme Kierulf-Vieira
collection DOAJ
description Evidence suggests that the growth and therapeutic resistance of glioblastoma (GBM) may be enabled by a population of glioma stem cells (GSCs) that are regulated by typical stem cell pathways, including the WNT/β-catenin signaling pathway. We wanted to explore the effect of treating GSCs with a small-molecule inhibitor of tankyrase, G007-LK, which has been shown to be a potent modulator of the WNT/β-catenin and Hippo pathways in colon cancer. Four primary GSC cultures and two primary adult neural stem cell cultures were treated with G007-LK and subsequently evaluated through the measurement of growth characteristics, as well as the expression of WNT/β-catenin and Hippo signaling pathway-related proteins and genes. Treatment with G007-LK decreased in vitro proliferation and sphere formation in all four primary GSC cultures in a dose-dependent manner. G007-LK treatment altered the expression of key downstream WNT/β-catenin and Hippo signaling pathway-related proteins and genes. Finally, cotreatment with the established GBM chemotherapeutic compound temozolomide (TMZ) led to an additive reduction in sphere formation, suggesting that WNT/β-catenin signaling may contribute to TMZ resistance. These observations suggest that tankyrase inhibition may serve as a supplement to current GBM therapy, although more work is needed to determine the exact downstream mechanisms involved.
first_indexed 2024-03-10T19:02:40Z
format Article
id doaj.art-e5684aa403ca47329369cac9db4d7ecf
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T19:02:40Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-e5684aa403ca47329369cac9db4d7ecf2023-11-20T04:22:02ZengMDPI AGCancers2072-66942020-06-01126163010.3390/cancers12061630A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere FormationKirsten Strømme Kierulf-Vieira0Cecilie Jonsgar Sandberg1Jo Waaler2Kaja Lund3Erlend Skaga4Birthe Mikkelsen Saberniak5Ioannis Panagopoulos6Petter Brandal7Stefan Krauss8Iver Arne Langmoen9Einar Osland Vik-Mo10Vilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research and Department of Neurosurgery, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, NorwayVilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research and Department of Neurosurgery, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, NorwayDepartment of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, NorwayDepartment of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, NorwayVilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research and Department of Neurosurgery, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, NorwayVilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research and Department of Neurosurgery, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, NorwaySection for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, P.O. Box 49534 Nydalen, 0424 Oslo, NorwaySection for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, P.O. Box 49534 Nydalen, 0424 Oslo, NorwayDepartment of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, NorwayVilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research and Department of Neurosurgery, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, NorwayVilhelm Magnus Laboratory for Neurosurgical Research, Institute for Surgical Research and Department of Neurosurgery, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, NorwayEvidence suggests that the growth and therapeutic resistance of glioblastoma (GBM) may be enabled by a population of glioma stem cells (GSCs) that are regulated by typical stem cell pathways, including the WNT/β-catenin signaling pathway. We wanted to explore the effect of treating GSCs with a small-molecule inhibitor of tankyrase, G007-LK, which has been shown to be a potent modulator of the WNT/β-catenin and Hippo pathways in colon cancer. Four primary GSC cultures and two primary adult neural stem cell cultures were treated with G007-LK and subsequently evaluated through the measurement of growth characteristics, as well as the expression of WNT/β-catenin and Hippo signaling pathway-related proteins and genes. Treatment with G007-LK decreased in vitro proliferation and sphere formation in all four primary GSC cultures in a dose-dependent manner. G007-LK treatment altered the expression of key downstream WNT/β-catenin and Hippo signaling pathway-related proteins and genes. Finally, cotreatment with the established GBM chemotherapeutic compound temozolomide (TMZ) led to an additive reduction in sphere formation, suggesting that WNT/β-catenin signaling may contribute to TMZ resistance. These observations suggest that tankyrase inhibition may serve as a supplement to current GBM therapy, although more work is needed to determine the exact downstream mechanisms involved.https://www.mdpi.com/2072-6694/12/6/1630glioblastomaglioma stem cellstankyrasetemozolomideβ-cateninWNT
spellingShingle Kirsten Strømme Kierulf-Vieira
Cecilie Jonsgar Sandberg
Jo Waaler
Kaja Lund
Erlend Skaga
Birthe Mikkelsen Saberniak
Ioannis Panagopoulos
Petter Brandal
Stefan Krauss
Iver Arne Langmoen
Einar Osland Vik-Mo
A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
Cancers
glioblastoma
glioma stem cells
tankyrase
temozolomide
β-catenin
WNT
title A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
title_full A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
title_fullStr A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
title_full_unstemmed A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
title_short A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation
title_sort small molecule tankyrase inhibitor reduces glioma stem cell proliferation and sphere formation
topic glioblastoma
glioma stem cells
tankyrase
temozolomide
β-catenin
WNT
url https://www.mdpi.com/2072-6694/12/6/1630
work_keys_str_mv AT kirstenstrømmekierulfvieira asmallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT ceciliejonsgarsandberg asmallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT jowaaler asmallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT kajalund asmallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT erlendskaga asmallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT birthemikkelsensaberniak asmallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT ioannispanagopoulos asmallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT petterbrandal asmallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT stefankrauss asmallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT iverarnelangmoen asmallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT einaroslandvikmo asmallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT kirstenstrømmekierulfvieira smallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT ceciliejonsgarsandberg smallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT jowaaler smallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT kajalund smallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT erlendskaga smallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT birthemikkelsensaberniak smallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT ioannispanagopoulos smallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT petterbrandal smallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT stefankrauss smallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT iverarnelangmoen smallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation
AT einaroslandvikmo smallmoleculetankyraseinhibitorreducesgliomastemcellproliferationandsphereformation